Forte Capital’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.63M | Sell |
4,026
-46
| -1% | -$19.2K | 0.18% | 95 |
|
|
2025
Q1 | $2.03M | Buy |
4,072
+572
| +16% | +$310K | 0.24% | 80 |
|
|
2024
Q4 | $1.82M | Sell |
3,500
-364
| -9% | -$200K | 0.2% | 83 |
|
|
2024
Q3 | $2.39M | Sell |
3,864
-157
| -4% | -$92.9K | 0.27% | 72 |
|
|
2024
Q2 | $2.22M | Sell |
4,021
-113
| -3% | -$64.7K | 0.27% | 68 |
|
|
2024
Q1 | $2.4M | Sell |
4,134
-83
| -2% | -$46.6K | 0.3% | 64 |
|
|
2023
Q4 | $2.24M | Sell |
4,217
-371
| -8% | -$180K | 0.31% | 63 |
|
|
2023
Q3 | $2.32M | Sell |
4,588
-10
| -0.2% | -$5.33K | 0.36% | 57 |
|
|
2023
Q2 | $2.4M | Sell |
4,598
-88
| -2% | -$47.5K | 0.35% | 59 |
|
|
2023
Q1 | $2.7M | Hold |
4,686
| – | – | 0.41% | 53 |
|
|
2022
Q4 | $2.58M | Sell |
4,686
-218
| -4% | -$116K | 0.44% | 50 |
|
|
2022
Q3 | $2.49M | Buy |
4,904
+54
| +1% | +$30.2K | 0.45% | 51 |
|
|
2022
Q2 | $2.63M | Sell |
4,850
-458
| -9% | -$252K | 0.46% | 52 |
|
|
2022
Q1 | $3.54M | Hold |
5,308
| – | – | 0.45% | 45 |
|
|
2021
Q4 | $3.54M | Buy |
5,308
+1,900
| +56% | +$1.19M | 0.45% | 45 |
|
|
2021
Q3 | $1.95M | Sell |
3,408
-75
| -2% | -$41.2K | 0.26% | 60 |
|
|
2021
Q2 | $1.76M | Sell |
3,483
-165
| -5% | -$77.9K | 0.24% | 69 |
|
|
2021
Q1 | $1.67M | Sell |
3,648
-25
| -0.7% | -$11.9K | 0.26% | 62 |
|
|
2020
Q4 | $1.71M | Sell |
3,673
-471
| -11% | -$221K | 0.26% | 60 |
|
|
2020
Q3 | $1.83M | Sell |
4,144
-94
| -2% | -$38.8K | 0.34% | 52 |
|
|
2020
Q2 | $1.54M | Buy |
+4,238
| New | +$1.42M | 0.32% | 56 |
|
|
2018
Q1 | – | Sell |
-7,183
| Closed | -$1.36M | – | 155 |
|
|
2017
Q4 | $1.36M | Sell |
7,183
-600
| -8% | -$115K | 0.41% | 61 |
|
|
2017
Q3 | $1.47M | Sell |
7,783
-170
| -2% | -$30.8K | 0.47% | 52 |
|
|
2017
Q2 | $1.39M | Sell |
7,953
-100
| -1% | -$16.8K | 0.46% | 55 |
|
|
2017
Q1 | $1.24M | Sell |
8,053
-1,065
| -12% | -$163K | 0.42% | 60 |
|
|
2016
Q4 | $1.29M | Sell |
9,118
-300
| -3% | -$44.2K | 0.48% | 57 |
|
|
2016
Q3 | $1.5M | Sell |
9,418
-400
| -4% | -$61.6K | 0.57% | 49 |
|
|
2016
Q2 | $1.45M | Sell |
9,818
-650
| -6% | -$95.9K | 0.56% | 49 |
|
|
2016
Q1 | $1.48M | Sell |
10,468
-375
| -3% | -$50.3K | 0.65% | 46 |
|
|
2015
Q4 | $1.54M | Sell |
10,843
-300
| -3% | -$40K | 0.63% | 45 |
|
|
2015
Q3 | $1.36M | Sell |
11,143
-213
| -2% | -$27.8K | 0.62% | 45 |
|
|
2015
Q2 | $1.47M | Sell |
11,356
-159
| -1% | -$20.7K | 0.63% | 43 |
|
|
2015
Q1 | $1.56M | Sell |
11,515
-295
| -2% | -$38K | 0.67% | 41 |
|
|
2014
Q4 | $1.48M | Sell |
11,810
-525
| -4% | -$63.8K | 0.64% | 44 |
|
|
2014
Q3 | $1.5M | Buy |
+12,335
| New | +$1.5M | 0.69% | 44 |
|
Other funds holding TMO
Forte Capital's TMO Position: Q2 2025 in Review
Forte Capital reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2025, selling an estimated $19.2K and leaving 4,026 shares worth $1.63M. The position accounts for 0.18% of the portfolio, ranked #95.
Forte Capital first reported a position in TMO in Q3 2014 and has held it in 35 quarters since. The position peaked at $3.54M in Q1 2022. 2,458 funds tracked by Wall St. Rank hold TMO as of Q2 2025.
- Forte Capital held 4,026 shares of Thermo Fisher Scientific worth $1.63M as of Q2 2025.
- Forte Capital sold 46 Thermo Fisher Scientific shares in Q2 2025, an estimated $19.2K.
- Thermo Fisher Scientific made up 0.18% of Forte Capital's portfolio in Q2 2025, its #95 holding.
- Forte Capital first reported a position in Thermo Fisher Scientific in Q3 2014 and has held it in 35 quarters since.
- Forte Capital's Thermo Fisher Scientific position peaked at $3.54M in Q1 2022.
- 2,458 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.
Based on Forte Capital's 13F filing for Q2 2025, filed 15 Jul 2025.